Enzo Biochem, Inc. (MUN:EZB)

Enzo Biochem Ratios and Metrics

Market cap in millions EUR. Fiscal year is August - July.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jul 3, 2025	Jul 31, 2024	Jul 31, 2023	Jul 31, 2022	Jul 31, 2021	Jul 31, 2020
Market Capitalization	30	54	67	113	133	96
Market Cap Growth	-55.50%	-18.84%	-41.01%	-15.02%	38.26%	-42.33%
Enterprise Value	2	8	84	103	121	79
PE Ratio	-	-	3.63	-	20.07	-
PS Ratio	1.26	1.84	2.37	3.54	1.34	1.50
PB Ratio	0.80	1.05	0.94	2.12	2.30	1.95
P/TBV Ratio	0.80	1.05	0.94	2.12	2.60	2.26
P/OCF Ratio	-	-	-	-	408.32	-
EV/Sales Ratio	0.08	0.28	2.99	3.21	1.22	1.23
EV/EBITDA Ratio	-	-	-	-	42.78	-
EV/EBIT Ratio	-	-	-	-	206.81	-
EV/FCF Ratio	-0.13	-	-	-	-	-
Debt / Equity Ratio	0.07	0.06	0.09	0.17	0.33	0.56
Debt / EBITDA Ratio	-	-	-	-	2.57	-
Asset Turnover	0.35	0.31	0.32	0.35	1.04	0.69
Inventory Turnover	2.41	2.34	2.23	1.73	6.28	6.69
Quick Ratio	2.41	2.27	2.18	2.03	2.06	1.74
Current Ratio	2.84	2.83	2.46	3.29	2.71	2.10
Return on Equity (ROE)	-13.95%	-14.59%	-37.65%	-33.06%	12.40%	-39.50%
Return on Assets (ROA)	-8.98%	-7.44%	-15.66%	-11.57%	0.38%	-17.32%
Return on Capital (ROIC)	-11.49%	-10.65%	-20.73%	-14.14%	0.47%	-20.83%
Return on Capital Employed (ROCE)	-	-	-	-	0.80%	-
Earnings Yield	-60.94%	-44.45%	27.57%	-15.82%	4.98%	-25.02%
FCF Yield	-47.26%	-45.69%	-53.99%	-17.38%	-2.56%	-16.98%
Buyback Yield / Dilution	-3.46%	-3.54%	-1.17%	-0.56%	-1.32%	-0.46%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.